Functional inhibition of intestinal and uterine muscles by non-permeant triphenylethylene derivatives

European Journal of Pharmacology

Volumn 532, Issue 1-2, 2006, Pages 115-127

  Marrero Alonso, Jorge ^a   García Marrero, Benito ^b   Gómez, Tomás ^a   Díaz, Mario ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b INSTITUTO DE PRODUCTOS NATURALES Y AGROBIOLOGÍA   (Spain)

Author keywords

Ca2+ channels; Impermeant triphenylethylene salts; Intestinal muscle; Non genomic effects; Tamoxifen derivatives; Uterine muscle

Indexed keywords

1,1,2 TRIPHENYLETHYLENE DERIVATIVE; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL]PYRIDINE 3 CARBOXILIC ACID METHYL ESTER; BAY K 644; BUTYLBROMIDE TAMOXIFEN; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM CHLORIDE; ETHYLBROMIDE TAMOXIFEN; INORGANIC SALT; N DESMETHYL TAMOXIFEN; NITROGEN; TAMOXIFEN; TAMOXIFEN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; EXPOSURE; FEMALE; FOURIER ANALYSIS; INHIBITION KINETICS; INTESTINE CONTRACTION; INTESTINE MUSCLE; MALE; MOUSE; MUSCLE CONTRACTILITY; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ACETYLCHOLINE; ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHLORIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; ESTROGEN ANTAGONISTS; FEMALE; MALE; MICE; MOLECULAR STRUCTURE; MUSCLE CONTRACTION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHLORIDE; STRUCTURE-ACTIVITY RELATIONSHIP; TAMOXIFEN; TRITYL COMPOUNDS; UTERUS; VASODILATOR AGENTS;

EID: 33644555201     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.031     Document Type: Article

References (40)

1. M.C. Allen, P.A. Gale, A.C. Hunter, A. Lloyd, and S.P. Hardy Membrane impermeant antioestrogens discriminate between ligand-and voltage-gated cation channels in NG108-15 cells Biochim. Biophys. Acta 1509 2000 229 236
2. B.G. Allen, and M.P. Walsh The biochemical basis of the regulation of smooth-muscle contraction TIBS 19 1994 362 368
3. M.C. Allen, C. Newland, M.A. Valverde, and S.P. Hardy Inhibition of ligand-gated cation-selective channels by tamoxifen Eur. J. Pharmacol. 354 1998 261 269
4. S. Batra Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes Cancer Chemother. Pharmacol. 26 1990 310 312
5. L.J. Brandes, L.M. McDonald, and R.P. Bogdanovic Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels Cancer Res. 47 1987 4025 4031
6. B. Cantabrana, and A. Hidalgo Effects of nonsteroidal antiestrogens in the in vitro rat uterus Pharmacology 45 1992 329 337
7. G. Coruzzi, and E. Poli The stimulatory action of the calcium channel agonist Bay K8644 on isolated duodenal muscle. Antagonism by nifedipine and verapamil Naunyn-Schmiedeberg's Arch. Pharmacol. 331 1985 290 292
8. M. Díaz Triphenylethylene antiestrogen-induced acute relaxation of mouse duodenal muscle. Possible involvement of calcium channels Eur. J. Pharmacol. 445 2002 257 266
9. - channels by triphenylethylene antiestrogens in C1300 neuroblastoma cells J. Physiol. 536 2001 79 88
10. M. Díaz, C.M. Ramirez, R. Marin, J. Marrero-Alonso, T. Gomez, and R. Alonso Acute relaxation of mouse duodenun by estrogens. Evidence for an estrogen receptor-independent modulation of muscle excitability Eur. J. Pharmacol. 501 2004 161 178
11. + currents Br. J. Pharmacol. 127 1999 1819 1831
12. G.M. Dick, C.F. Rossow, S. Smirnov, B. Horowitz, and K.M. Sanders Tamoxifen activates smooth muscle BK channels through the regulatory beta 1 subunit J. Biol. Chem. 276 2001 34594 34599
13. G.M. Dick, A.C. Hunter, and K.M. Sanders Ethylbromide tamoxifen, a membrane-impermeant antiestrogen, activates smooth muscle calcium-activated large-conductance potassium channels from the extracellular side Mol. Pharmacol. 61 2002 1105 1113
14. G.A. Figtree, C.M. Webb, and P. Collins Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism J. Pharmacol. Exp. Ther. 295 2000 519 523
15. D.A. Greenberg, C.L. Carpenter, and R.O. Messing Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cells Cancer Res. 47 1987 70 74
16. S.P. Hardy, C. deFelipe, and M.A. Valverde Inhibition of voltage-gated cationic channels in rat embrionic hypothalamic neurones and C1300 neuroblastoma cells by triphenylethylene antiestrogens FEBS Lett. 434 1998 239 240
17. C. Hiemke, and R. Ghraf Interaction of non-steroidal antiestrogens with dopamine receptor binding J. Steroid Biochem. 21 1984 663 667
18. K. Horgan, E. Cooke, M.B. Hallet, and R.E. Mansel Inhibition of protein kinase C mediated signal transduction by tamoxifen Biochem. Pharmacol. 35 1986 4463 4465
19. M. Jarman, O.T. Leung, G. Leclercq, N. Devleeschouwer, S. Stoessel, R.C. Coombes, and R.A. Skilton Analogues of tamoxifen: the role of the basic side-chain. Applications of a whole-cell oestrogen-receptor binding assay to N-oxides and quaternary salts Anti-Cancer Drug Des. 1 1986 259 268
20. V.C. Jordan, and C.S. Murphy Endocrine pharmacology of antiestrogens as antitumor agents Endocr. Rev. 11 1990 579 610
21. J. Kirk, S.K. Syed, A.L. Harris, M. Jarman, B.D. Roufogalis, I.J. Stratford, and J. Carmichael Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives Biochem. Pharmacol. 48 1994 277 285
22. A. Kostrzewska, T. Laudanski, and S. Batra Potent inhibition by tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries Am. J. Obstet. Gynecol. 176 1997 381 386
23. H.Y. Lam Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase Biochem. Biophys. Res. Comm. 118 1984 27 32
24. J.C. Lee, L. Thuneberg, I. Berezin, and J.D. Huizinga Generation of slow waves in membrane potential is an intrinsic property of intersticial cells of Cajal Am. J. Physiol. 277 1999 G409 G423
25. A. Lipton, and I.D. Morris Calcium antagonism by the antiestrogen tamoxifen Cancer Chemother. Pharmacol. 18 1986 17 20
26. A. Lipton, A. Vinijsanum, and L. Martin Acute inhibition of rat myometrial responses to oxytocin by tamoxifen steroisomers and estradiol J. Endocrinol. 103 1984 383 388
27. 2+] and diameter in mouse cerebral arteries J. Appl. Physiol. 91 2001 1350 1354
28. 2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain Cancer Res. 50 1990 2753 2758
29. 2+ exchange of brain cortex membranes Biochem. Pharmacol. 40 1990 1877 1884
30. R.A. Meiss Mechanical properties of gastrointestinal smooth muscle L.R. Johnson Physiology of the Gastrointestinal Tract 1987 Raven Press New York, NY 273 329
31. C.S. Murphy, and V.C. Jordan Structural components necessary for the antiestrogenic activity of tamoxifen J. Steroid Biochem. 34 1989 407 411
32. R.A. Olofson, R.C. Schnur, L. Bunes, and J.P. Pepe Selective N-Dealkylation of tertiary amines with vinyl chloroformate: an improved synthesis of naloxone Tetrahedron Lett. 18 1977 1567 1570
33. P.H. Ratz, K.A. MacCammon, D. Altstatt, P.F. Blackmore, O.Z. Shenfeld, and S.M. Schlossberg Differential effects of sex hormones and phystoestrogens on peak and steady state contractions in isolated rabbit detrusor J. Urol. 162 1999 1821 1828
34. P. Sartor, P. Vacher, P. Mollard, and B. Dufy Tamoxifen reduces calcium currents in a clonal pituitary cell line Endocrinology 123 1988 534 540
35. M. Schramm, G. Thomas, R. Towart, and G. Franckowiak Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics of smooth muscle stimulants Arzneimittelforsch 33 1983 1268 1272
36. + currents by tamoxifen J. Membr. Biol. 181 2001 125 135
37. J. Song, P.R. Standley, F. Zhang, D. Joshi, S. Gappy, J.R. Sowers, and J.L. Ram Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats J. Pharmacol. Exp. Ther. 277 1996 1444 1453
38. D.L. Trump, D.C. Smith, P.G. Ellis, M.P. Rogers, S.C. Schold, E.P. Winer, T.J. Panella, V.C. Jordan, and R.L. Fine High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine J. Natl. Cancer Inst. 84 1992 1811 1816
39. S. Wray, S. Kupittayanant, A. Shmygol, R.D. Smith, and T. Burdyga The physiological basis of uterine contractility: a short review Exp. Physiol. 86 2001 239 246
40. J.J. Zhang, T.J.C. Jacob, M.A. Valverde, S.P. Hardy, G.M. Mintenig, F.V. Sepúlveda, D.R. Gill, S.C. Hyde, A.E.O. Trezise, and C.F. Higgins Tamoxifen blocks chloride channels: a possible mechanism for cataract formation J. Clin. Invest. 94 1994 1690 1697